|
|
|
|
|
|
|
|
By AR Welch, Editorial & Community Director, Advancing RNA | Here, in part one of this two-part article, we identify how tRNA stands apart from other RNA modalities and gene therapies, as well as how this molecule’s unique “skill set” is guiding the company’s future clinical strategy. | |
|
|
|
| Improving Toxicology Testing For Inhalation Products | Article | Battelle | By embracing new approach methods, regulatory agencies can revolutionize toxicology testing. These methods can be adapted for various medications, including inhalers and nasal-administered drugs. |
|
|
|
| High-Throughput Lipid Separation For LNP Formulations | Application Note | KNAUER | Lipid nanoparticles (LNPs) carry immense potential as delivery systems. Learn about the development of isocratic and gradient methods for high-throughput separation of lipids used in LNP formulations. |
|
|
|
|
| Can mRNA Disrupt The Biopharma Industry? | White Paper | By Amélie Boulais and Piergiuseppe Nestola, Sartorius | mRNA has the potential to revolutionize the field of vaccine development. However, it is critical we understand any factors that could impact its successful entry into today’s market. |
|
|
|
| The Current And Future Value Of mRNA Vaccines And Therapeutics | White Paper | By Norman Garceau, Ph.D., Jordon Wang, Ph.D., and Scott Alderucci, Curia | Discover how decades of research have propelled mRNA technology to the forefront of therapeutic development and learn how our expertise is advancing mRNA drug development. |
|
|
.png){kind=logo}
